Drawing for ARDENT

USPTO serial 98852850

ARDENT

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
CARR, PATRICK C
Law office
TMO LAW OFFICE 125

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ARDENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mary Frances Love

Mary Frances Love Muncy, Geissler, Olds & Lowe, P.C.125 S. Royal St.Alexandria, VA 22314United States

Goods and services

ClassDescriptionStatusFirst use
037Construction services, namely, road construction, general construction contracting; transportation construction, namely, street construction; real estate construction, namely, real estate development and construction of commercial, residential and hotel property; municipal projects construction, namely, construction of municipal infrastructure facilities ; construction services, namely, concrete paving, site clearing, excavation, grading, and asphalt paving services; construction of bridges; installation and maintenance of traffic signals, lighting, and Intelligent Transportation Systems in the nature of traffic control apparatusACTIVE—
042Civil engineering relating to infrastructure, and utility installations and facilities; electrical and industrial engineering; geotechnical and structural engineeringACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 5, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 5, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 7, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 7, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Apr 7, 2026CNSLSUSPENSION LETTER WRITTEN—
Feb 19, 2026DOCKASSIGNED TO EXAMINER—
Oct 30, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 30, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 30, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 12, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Sep 12, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jun 12, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 9, 2025DOCKASSIGNED TO EXAMINER—
May 7, 2025MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 7, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 14, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance